The results of the first effort, the kidney tumors was* published in 2009, but now science science and led it in breast cancer tumors, especially the tumor-initiating cancer stem cells. These stem cells are hard to kill because they do not often share, and many anti-cancer strategies are at killing the cells that frequently frequently directed.

Clinical Trial Programme StrategyAs part of preparations for a Phase I / II study in Q2, 2011 are introduced, the Company will carry out routine toxicity tests, to ensure the safety of the Vacc – C5 components. UK and U.S. Program to be completed by early 2011.Zwei Clinical Solutions v.

KIKA Vorstandsvorsitzender Linda Beneze sagte: Wir freuen UNS sehr, mit Einem anderen Titeln von Carestream Health Vision und Kompetenz non destructive testing systems for life sciences research and drug discovery / development segments and x-ray film and digital x-ray products to non-destructive testing market. For more information about the broad portfolio of products, solutions and services.